{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:41:23Z","timestamp":1793648483029,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203337"],"award-info":[{"award-number":["82203337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MSLH-542"],"award-info":[{"award-number":["2024-MSLH-542"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200160"],"award-info":[{"award-number":["2023JH2\/20200160"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Applied Basic Research Program","award":["2023JH2\/101600012"],"award-info":[{"award-number":["2023JH2\/101600012"]}]},{"name":"Liaoning Province Central Guidance Local Science and Technology Development Fund Plan","award":["2024JH6\/100800018"],"award-info":[{"award-number":["2024JH6\/100800018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"DOI":"10.1186\/s13046-025-03561-x","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:24:35Z","timestamp":1765290275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The simultaneous targeted Inhibition of ISG15 and HMGCR disrupts cancer stemness through metabolic collapse and induces synthetic lethality in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"44","author":[{"given":"Jia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Xian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"8","key":"3561_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, et al. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"5","key":"3561_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk Assessment, early Detection, and prevention. Gastroenterology. 2023;164(5):752\u201365.","journal-title":"Gastroenterology"},{"issue":"1","key":"3561_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-024-01613-x","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Consensus, debate, and prospective on pancreatic cancer treatments. J Hematol Oncol. 2024;17(1):92.","journal-title":"J Hematol Oncol"},{"key":"3561_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.05.001","volume":"148","author":"K Zhu","year":"2020","unstructured":"Zhu K, Xie V, Huang S. Epigenetic regulation of cancer stem cell and tumorigenesis. Adv Cancer Res. 2020;148:1\u201326.","journal-title":"Adv Cancer Res"},{"issue":"5","key":"3561_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31(5):617\u201339.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"3561_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, et al. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31(8):1101\u201312.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3561_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41571-024-00966-z","volume":"22","author":"NYL Ngoi","year":"2025","unstructured":"Ngoi NYL, et al. Synthetic lethal strategies for the development of cancer therapeutics. Nat Rev Clin Oncol. 2025;22(1):46\u201364.","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"3561_CR8","doi-asserted-by":"publisher","first-page":"11488","DOI":"10.1021\/acs.jmedchem.4c00113","volume":"67","author":"V Previtali","year":"2024","unstructured":"Previtali V, et al. New horizons of synthetic lethality in cancer: current development and future perspectives. J Med Chem. 2024;67(14):11488\u2013521.","journal-title":"J Med Chem"},{"key":"3561_CR9","doi-asserted-by":"crossref","unstructured":"Mathieu NA et al. HERC5 and the isgylation pathway: critical modulators of the antiviral immune response. Viruses, 2021. 13(6).","DOI":"10.3390\/v13061102"},{"key":"3561_CR10","doi-asserted-by":"crossref","unstructured":"Mirzalieva O et al. ISG15 and isgylation in human diseases. Cells, 2022. 11(3).","DOI":"10.3390\/cells11030538"},{"key":"3561_CR11","doi-asserted-by":"crossref","unstructured":"Qin Y et al. Posttranslational isgylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation. J Clin Invest, 2023. 133(20).","DOI":"10.1172\/JCI161935"},{"issue":"5","key":"3561_CR12","doi-asserted-by":"publisher","first-page":"114135","DOI":"10.1016\/j.celrep.2024.114135","volume":"43","author":"Y Qin","year":"2024","unstructured":"Qin Y, et al. ISGylation by HERCs facilitates STING activation. Cell Rep. 2024;43(5):114135.","journal-title":"Cell Rep"},{"issue":"3","key":"3561_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41388-019-0992-2","volume":"39","author":"J Sun","year":"2020","unstructured":"Sun J, et al. Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation. Oncogene. 2020;39(3):546\u201359.","journal-title":"Oncogene"},{"issue":"4","key":"3561_CR14","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.7150\/ijbs.85424","volume":"20","author":"Y Meng","year":"2024","unstructured":"Meng Y, et al. ISG15 promotes progression and gemcitabine resistance of pancreatic cancer cells through ATG7. Int J Biol Sci. 2024;20(4):1180\u201393.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"3561_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.trecan.2024.03.004","volume":"10","author":"M Merteroglu","year":"2024","unstructured":"Merteroglu M, Santoro MM. Exploiting the metabolic vulnerability of Circulating tumour cells. Trends Cancer. 2024;10(6):541\u201356.","journal-title":"Trends Cancer"},{"issue":"8","key":"3561_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","volume":"186","author":"LWS Finley","year":"2023","unstructured":"Finley LWS. What is cancer metabolism? Cell. 2023;186(8):1670\u201388.","journal-title":"Cell"},{"issue":"9","key":"3561_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo A, Gui DY. Vander Heiden, Targeting metabolism for cancer therapy. Cell Chem Biol. 2017;24(9):1161\u201380.","journal-title":"Cell Chem Biol"},{"issue":"8","key":"3561_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, et al. Emerging therapies in cancer metabolism. Cell Metab. 2023;35(8):1283\u2013303.","journal-title":"Cell Metab"},{"key":"3561_CR19","doi-asserted-by":"crossref","unstructured":"Jiang R et al. Statins in mitigating anticancer Treatment-Related cardiovascular disease. Int J Mol Sci, 2024. 25(18).","DOI":"10.3390\/ijms251810177"},{"issue":"5","key":"3561_CR20","first-page":"e2078","volume":"7","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Gupta E, Galande S. Statins as anti-tumor agents: A paradigm for repurposed drugs. Cancer Rep (Hoboken). 2024;7(5):e2078.","journal-title":"Cancer Rep (Hoboken)"},{"key":"3561_CR21","doi-asserted-by":"crossref","unstructured":"Won EJ et al. Gene therapy using nanocarriers for pancreatic ductal adenocarcinoma: applications and challenges in cancer therapeutics. Pharmaceutics, 2022. 14(1).","DOI":"10.3390\/pharmaceutics14010137"},{"issue":"9","key":"3561_CR22","doi-asserted-by":"publisher","first-page":"14149","DOI":"10.1021\/acsnano.0c08860","volume":"15","author":"X Zhao","year":"2021","unstructured":"Zhao X, et al. Penetration cascade of size switchable nanosystem in desmoplastic stroma for improved pancreatic cancer therapy. ACS Nano. 2021;15(9):14149\u201361.","journal-title":"ACS Nano"},{"issue":"4","key":"3561_CR23","doi-asserted-by":"publisher","first-page":"e1983","DOI":"10.1002\/wnan.1983","volume":"16","author":"H Agarwal","year":"2024","unstructured":"Agarwal H, et al. Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16(4):e1983.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"3","key":"3561_CR24","doi-asserted-by":"publisher","first-page":"104320","DOI":"10.1016\/j.drudis.2025.104320","volume":"30","author":"S Kumari","year":"2025","unstructured":"Kumari S, et al. Polysaccharides as therapeutic vehicles in pancreatic cancer. Drug Discov Today. 2025;30(3):104320.","journal-title":"Drug Discov Today"},{"issue":"9","key":"3561_CR25","first-page":"851","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic Cancer: Rev JAMA. 2021;326(9):851\u201362.","journal-title":"Pancreatic Cancer: Rev JAMA"},{"issue":"7","key":"3561_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam SM, et al. A multi-omics investigation of the composition and function of extracellular vesicles along the Temporal trajectory of COVID-19. Nat Metab. 2021;3(7):909\u201322.","journal-title":"Nat Metab"},{"issue":"1","key":"3561_CR27","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3561_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori KJ, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9(3):205\u201317.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"3561_CR29","doi-asserted-by":"publisher","first-page":"e7345","DOI":"10.1002\/cam4.7345","volume":"13","author":"G Giordano","year":"2024","unstructured":"Giordano G, et al. Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment. Cancer Med. 2024;13(12):e7345.","journal-title":"Cancer Med"},{"issue":"4","key":"3561_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, et al. Pancreatic Adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"3561_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00262-024-03632-6","volume":"73","author":"X Ye","year":"2024","unstructured":"Ye X, et al. Clinical immunotherapy in pancreatic cancer. Cancer Immunol Immunother. 2024;73(4):64.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"3561_CR32","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s12029-024-01054-2","volume":"55","author":"K Drougkas","year":"2024","unstructured":"Drougkas K, et al. CAR-T cell therapy in pancreatic and biliary tract cancers: an updated review of clinical trials. J Gastrointest Cancer. 2024;55(3):990\u20131003.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"3561_CR33","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1038\/s41467-020-16395-2","volume":"11","author":"S Alcala","year":"2020","unstructured":"Alcala S, et al. ISG15 and isgylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity. Nat Commun. 2020;11(1):2682.","journal-title":"Nat Commun"},{"issue":"12","key":"3561_CR34","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s00262-019-02422-9","volume":"68","author":"J Burks","year":"2019","unstructured":"Burks J, et al. ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression. Cancer Immunol Immunother. 2019;68(12):2029\u201339.","journal-title":"Cancer Immunol Immunother"},{"key":"3561_CR35","doi-asserted-by":"crossref","unstructured":"Bubin R, Uljanovs R, Strumfa I. Cancer stem cells in pancreatic ductal adenocarcinoma. Int J Mol Sci, 2023. 24(8).","DOI":"10.3390\/ijms24087030"},{"key":"3561_CR36","doi-asserted-by":"crossref","unstructured":"Biserova K et al. Cancer stem cells: significance in Origin, pathogenesis and treatment of glioblastoma. Cells, 2021. 10(3).","DOI":"10.3390\/cells10030621"},{"issue":"49","key":"3561_CR37","doi-asserted-by":"publisher","first-page":"e2206765","DOI":"10.1002\/adma.202206765","volume":"34","author":"X Kang","year":"2022","unstructured":"Kang X, et al. Dual-Cascade responsive nanoparticles enhance pancreatic cancer therapy by eliminating Tumor-Resident intracellular bacteria. Adv Mater. 2022;34(49):e2206765.","journal-title":"Adv Mater"},{"key":"3561_CR38","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large DE, et al. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851.","journal-title":"Adv Drug Deliv Rev"},{"key":"3561_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2022.12.013","volume":"157","author":"F Raza","year":"2023","unstructured":"Raza F, et al. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomater. 2023;157:1\u201323.","journal-title":"Acta Biomater"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03561-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:12:37Z","timestamp":1781622757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03561-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3561"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03561-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Jia Sun and Jia-Mei Wang should be captured as equal contributors","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by and compiled with the guidelines of the Institutional Animal Care Committee of Nanjing University of Chinese Medicine(202403A057). This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}